CONMED Corp — Director's Dealing 2021

Sep 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2021-09-15

Reporting Person: Jonas Daniel S (EVP Legal Affairs,Gen. Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-15	Common Stock	S	3357	$127.2571	Disposed	10464	Direct
2021-09-15	Common Stock	M	11000	$59.96	Acquired	21464	Direct
2021-09-15	Common Stock	F	8327	$127.56	Disposed	13137	Direct
2021-09-15	Common Stock	G	1000	—	Disposed	12137	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-15	Options To Purchase Common Stock	$59.96	M	11000	Disposed	2028-03-01	Common Stock (11000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.20 to $127.265. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.